Drug efficacy : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-first Congress, first session.
| Corporate Authors: | United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee, ProQuest (Firm) |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
Washington :
U.S. Govt. Print. Off,
1970.
|
| Series: | U.S. Congressional Hearings.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book Connect to the full text of this electronic book |
Similar Items
FDA's regulation of the drug "Triazure" : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fourth Congress, second session, October 27, 1976.
Published: (1976)
Published: (1976)
FDA's regulation of the new drug Suprol : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, May 27, 1987.
Published: (1988)
Published: (1988)
Drug Safety. hearings before the United States House Committee on Government Operations, Subcommittee on Intergovernmental Relations, Eighty-Ninth Congress, first session, on July 20, 22, 27, Aug. 3, 10, Sept. 24, 1965.
Published: (1965)
Published: (1965)
Drug Safety. hearings before the United States House Committee on Government Operations, Subcommittee on Intergovernmental Relations, Eighty-Ninth Congress, first session, on Mar. 23, 24, May 4, June 8-10, 24, 25, 1965.
Published: (1965)
Published: (1965)
Food and drug law and regulation /
Published: (2008)
Published: (2008)
Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986.
Published: (1987)
Published: (1987)
Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991.
Published: (1991)
Published: (1991)
FDA's regulation of the marketing of unapproved new drugs : the case of E-Ferol vitamin E aqueous solution : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, second session, May 4, 1984.
Published: (1984)
Published: (1984)
FDA's regulation of Zomax : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, April 26 and 27, 1983.
Published: (1983)
Published: (1983)
The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982.
Published: (1982)
Published: (1982)
Animal Drug Amendments of 1965 : hearings before the United States House Committee on Interstate and Foreign Commerce, Subcommittee on Public Health and Welfare, Eighty-Ninth Congress, second session, on June 13, 1966.
Published: (1966)
Published: (1966)
Food and Drug Administration : reorganization and historical perspectives /
by: Dodge, Christopher H.
Published: (1979)
by: Dodge, Christopher H.
Published: (1979)
Food and Drug Administration : reorganization and historical perspectives /
by: Dodge, Christopher H.
Published: (1978)
by: Dodge, Christopher H.
Published: (1978)
Modernizing FDA's regulation of over-the-counter drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. September 13, 2017.
Published: (2018)
Published: (2018)
Drug approval : access to experimental drugs for severely ill patients /
by: Randall, Blanchard
Published: (1989)
by: Randall, Blanchard
Published: (1989)
Discussion draft of the Food and Drug Administration Globalization Act legislation : drug safety : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 1, 2008.
Published: (2008)
Published: (2008)
S. 1082, the Food and Drug Administration Revitalization Act.
Published: (2007)
Published: (2007)
Regulatory policies of the Food and Drug Administration : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-first Congress, second session, June 9, 1970.
Published: (1971)
Published: (1971)
Recall procedures of the Food and Drug Administration : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, first session. March 29, 1971.
Published: (1971)
Published: (1971)
FDA regulation of the new drug "Serc" : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, second session /
Published: (1972)
Published: (1972)
A system overwhelmed : the avalanche of imported, counterfeit, and unapproved drugs into the U.S. : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, June 24, 2003.
Published: (2003)
Published: (2003)
A system overwhelmed : the avalanche of imported, counterfeit, and unapproved drugs into the U.S. : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, June 24, 2003.
Published: (2003)
Published: (2003)
Regulation of over-the-counter drugs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, first session, June 22, 1979.
Published: (1979)
Published: (1979)
The Food, Drug, and Insecticide Administration ; its history, activities and organization /
by: Weber, Gustavus Adolphus, 1863-1942
Published: (1928)
by: Weber, Gustavus Adolphus, 1863-1942
Published: (1928)
FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988.
Published: (1989)
Published: (1989)
Drug Efficacy. hearings before the United States House Committee on Government Operations, Subcommittee on Intergovernmental Relations, Ninety-First Congress, first session, on May 13-15, 1969.
Published: (1969)
Published: (1969)
The safety and effectiveness of new drugs : (marketing of fixed combination drugs and unapproved new drugs; implementation of drug efficacy findings). Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, first session. May 26, 1971.
Published: (1971)
Published: (1971)
Drug Efficacy. hearings before the United States House Committee on Government Operations, Subcommittee on Intergovernmental Relations, Ninety-First Congress, first session, on Apr. 17, 18, 22, 1969.
Published: (1969)
Published: (1969)
Food and Drug Administration oversight : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session.
Published: (1991)
Published: (1991)
Food, drug, cosmetic, and device enforcement amendments : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2597, a bill to amend the Federal Food, Drug, and Cosmetic Act to enhance the enforcement authority of the Food and Drug Administration, July 17, 1991.
Published: (1991)
Published: (1991)
A practical guide to food and drug law and regulation /
Published: (2008)
Published: (2008)
The regulation of animal drugs by the Food and Drug Administration : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, first session, July 24 and 25, 1985.
Published: (1986)
Published: (1986)
Regulation of new drug R. & D. by the Food and Drug Administration, 1974 : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare, and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-third Congress, second session ... September 25 and 27, 1974.
Published: (1974)
Published: (1974)
Drug lag : hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, September 16, 1981.
Published: (1983)
Published: (1983)
Seizure of Foods and Drugs : hearings before the United States House Committee on Interstate and Foreign Commerce, Eightieth Congress, first session, on June 12, 1947.
Published: (1947)
Published: (1947)
"Man-in-the-plant", FDA's failure to regulate deceptive drug labeling : hearings before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, September 8 and 12, 1978.
Published: (1978)
Published: (1978)
FDA review times : statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives.
by: Hamilton, Mary R. (Mary Ruth), 1944-
Published: (1996)
by: Hamilton, Mary R. (Mary Ruth), 1944-
Published: (1996)
FDA administrative enforcement manual /
by: Parker, Florence R.
Published: (2005)
by: Parker, Florence R.
Published: (2005)
The Food and Drug Administration's critical mission and challenges for the future : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, May 1, 2007.
Published: (2007)
Published: (2007)
The Food and Drug Administration's critical mission and challenges for the future : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, May 1, 2007.
Published: (2007)
Published: (2007)